Doxorubicin alters Ca2+ transients but fails to change Ca2+ sensitivity of contractile proteins

Environmental Toxicology and Pharmacology

Volumn 1, Issue 2, 1996, Pages 131-139

  Temma, Kyosuke ^a   Chugun, Akihito ^a   Akera, Tai ^b   Kondo, Hiroshi ^a   Kurebayashi, Nagomi ^c  

^a KITASATO UNIVERSITY   (Japan)

^b Merck Sharp Dohm Res Labs Japan   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

Ca2+ sensitivity of contractile proteins; Ca2+ transient; Doxorubicin; Myocyte; Skinned fiber

Indexed keywords

CAVIA PORCELLUS; SUS SCROFA;

CALCIUM; CONTRACTILE PROTEIN; DOXORUBICIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARDIOTOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIASTOLE; GUINEA PIG; HEART ATRIUM; HEART MUSCLE CELL; MALE; MUSCLE TWITCH; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SKINNED MUSCLE FIBER;

EID: 0030014739     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/1382-6689(95)00021-6     Document Type: Article

References (42)

1. 2+ concentrations triggered by electrical stimulation of cardiac myocytes, Keio J. Med. 39, 168.
2. Agata, N., S. Hirano, Y. Hara, H. Iguchi, M. Shirai, H. Tone and N. Urakawa, 1991, A comparison of pirarubicin with other anthracyclines on the cardiovascular system, Pharmacometrics 41, 467.
3. Azuma, J., N. Sperelakis, H. Hasegawa, Y. Tanimoto, S. Vogel, K. Ogura, N. Awata, A. Sawamura, H. Harada, T. Ishiyama, Y. Morita and Y. Yamamura, 1981, Adriamycin cardiotoxicity: possible pathogenic mechanisms, J. Mol. Cell. Cardiol. 13, 381.
4. Bernardini, C. T.M. Del, R. Danesi and T.M. Della, 1986, The influence of amrinone on cardiac toxicity induced by adriamycin in rats, Arch. Int. Pharmacodyn. Ther. 283, 243.
5. Binah, O., I.S. Cohen and M.R. Rosen, 1983, The effects of adriamycin on normal and ouabain-toxic canine Purkinje and ventricular muscle fibers, Circ. Res. 53, 655.
6. 2+ transients and papillary muscle tension in guinea pigs, Anesthesiology 76, 123.
7. Boucek, R.J., S.H. Buck, F. Scott, N.L. Oquist, S. Fleicher, R.D. Olson and E. Okediji, 1993, Anthracycline-induced tension in permeabilized cardiac fibers: evidence for the activation of the calcium release channel of sarcoplasmic reticulum, J. Mol. Cell. Cardiol. 25, 249.
8. 2+ exchange of dog heart sarcolemmal vesicles, FEBS Lett. 130, 184.
9. Combs, A.B., D. Acosta and K. Ramos, 1985, Effects of doxorubicin and verapamil on calcium uptake in primary cultures of rat myocardial cells, Biochem. Pharmacol. 34, 1115.
10. 2+ mediated through α-and β-adrenoceptors. Circ. Res. 62, 247.
11. Fabiato, A., 1983, Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum, Am. J. Physiol. 245, C1.
12. 2+ transient in rat myocardium, J. Mol. Cell. Cardiol. 23, 325.
13. 2+] during inotropic interventions in isolated rat myocytes, J. Physiol. (London) 437, 351.
14. Gwathmey, J.K. and R.J. Hajjar, 1990, Intracellular calcium related to force development in twitch contraction of mammalian myocardium, Cell Calcium 11, 531.
15. Hagane, K., T. Akera and J.R. Berlin, 1988, Doxorubicin: mechanism of cardiodepressant actions in guinea pigs, J. Pharmacol. Exp. Ther. 246, 655.
16. Harada, H., B.J. Cusack, R.D. Olson, W. Stroo, J. Azuma, T. Hamaguchi and S.W. Schaffer, 1990, Taurine deficiency and doxorubicin: interaction with the cardiac sarcolemmal calcium pump, Biochem. Pharmacol. 39, 745.
17. Holmberg, S.R.M. and A.J. Williams, 1990, Patterns of interaction between anthraquinone drugs and the calcium-release channel from cardiac sarcoplasmic reticulum, Circ. Res. 67, 272.
18. Jensen, R., 1986, Doxorubicin cardiotoxicity: contractile changes after long-term treatment in the rat, J. Pharmacol. Exp. Ther. 236, 197.
19. 2+ transients and twitch contractions observed in single myocytes obtained from rat heart, Eur. J. Pharmacol. 266, 155.
20. 2+ transients observed in cardiac myocytes isolated from guinea-pig heart, Can. J. Physiol. Pharmacol. 72, 622.
21. Kim, D.-H., A.B. Landry III, Y.S. Lee and A.M. Katz, 1989, Doxorubicin-induced calcium release from cardiac sarcoplasmic reticulum vesicles, J. Mol. Cell. Cardiol. 21, 433.
22. Kitazawa, T., 1984, Effect of extracellular calcium on contractile activation in guinea-pig ventricular muscle, J. Physiol. (London) 355, 635.
23. Klugmann, S., B.F. Klugmann, G. Decorti, D. Gori, F. Silvestri and F. Camerini, 1981, Adriamycin experimental cardiomyopathy in Swiss mice. Different effects of two calcium antagonistic drugs on ADM-induced cardiomyopathy, Pharmacol. Res. Commun. 13, 769.
24. Konishi, M., S. Kurihara and T. Sakai, 1984, The effects of caffeine on tension development and intracellular calcium transients in rat ventricular muscle, J. Physiol. (London) 355, 605.
25. 2+]; in single heart cells, Am. J. Physiol. 261, H1115.
26. Kurebayashi, N. and S. Ogawa, 1991, Discrimination of calcium-ATPase activity of the sarcoplasmic reticulum from actomyosin-type ATPase activity of myofibrils in skinned mammalian ATPase activity, J. Musc. Res. Cell Motil. 1214, 355.
27. Kusuoka, H., S. Futaki, Y. Koretsune, A. Kitabatake, H. Suga, T. Kamada and M. Inoue, 1991, Alterations of intracellular calcium homeostasis and myocardial energetics in acute adriamycin-induced heart failure, J. Cardiovasc. Pharmacol. 18, 437.
28. Lattanzio, F.A., R.G. Schlatterer, M. Nicar, K.P. Cambell and J.L. Sutko, 1987, The effects of ryanodine on passive calcium fluxes across sarcoplasmic reticulum membranes, J. Biol. Chem. 262, 2711.
29. Liu, Q. and M. Vassalle, 1991, On the mechanism by which doxorubicin abolishes the oscillatory events induced by Ca overload in single cardiac myocytes, J. Cardiovasc. Pharmacol. 18, 711.
30. 2+ release channel of sarcoplasmic reticulum, J. Biol. Chem. 261, 6300.
31. Olson, R.D. and P.S. Mushlin, 1990, Doxorubicin cardiotoxicity: analysis of prevailing hypotheses, FASEB J. 4, 3076.
32. Olson H.M., D.M. Young, D.J. Prieur, A.F. LeRoy and R.L. Reagan, R.L, 1974, Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits, Am. J. Pathol. 77, 439.
33. Ondrias, K., L. Borgatta, H.H. Kim and B.E. Ehrlich, 1990, Biphasic effects of doxorubicin on the calcium release channel from sarcoplasmic reticulum of cardiac muscle, Circ. Res. 67, 1167.
34. 2+ release during diastole and systole in isolated rat ventricular myocytes, J. Physiol. (London) 430, 519.
35. 2+ release channel from rat cardiac sarcoplasmic reticulum: possible receptor-mediated mechanism of doxorubicin cardiomyopathy, Mol. Pharmacol. 37, 503.
36. Rabkin, S., M. Otten and P.I. Polimeni, 1983, Increased mortality with cardiotoxic doses of adriamycin after verapamil pretreatment despite prevention of myocardial calcium accumulation, Can. J. Physiol. Pharmacol. 61, 1050.
37. 2+ release from sarcoplasmic reticulum of skinned fast- and slow-twitch muscle fibers, Am. J. Physiol. 254, C459.
38. Sridhar, R., C. Dwivedi, I. Anderson, P.E. Baker, H.M. Sharma, P. Desai and F. N. Engineer, 1992, Effects of verapamil on the acute toxicity of doxorubicin in vivo, J. Nat. Cancer Inst. 84, 1653.
39. Temma, K., T. Akera, A. Chugun, H. Kondo, K. Hagane and S. Hirano, 1993 Comparison of cardiac actions of doxorubicin, pirarubicin and aclarubicin in isolated guinea-pig heart, Eur. J. Pharmacol. 234, 173.
40. 2+ loading and inotropic effects of doxorubicin in atrial muscle preparations isolated from rat or guinea-pig hearts, Eur. J. Pharmacol. 252, 173.
41. Thompson, R.B., K.D. Warber and J.D. Potter, 1990, Calcium at the myofilaments, In: Calcium and the Heart, ed. G.A. Langer (Raven Press, New York) p. 127.
42. Wendt, I.R. and D.G. Stephenson, 1983, Effects of caffeine on Caactivated force production in skinned cardiac and skeletal muscle fibres of the rat, Pflugers Arch. 398, 210.